These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 12881718)
1. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718 [TBL] [Abstract][Full Text] [Related]
2. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Jin J; You H; Yu B; Deng Y; Tang N; Yao G; Shu H; Yang S; Qin W Biochem Biophys Res Commun; 2009 Jan; 379(1):86-91. PubMed ID: 19100240 [TBL] [Abstract][Full Text] [Related]
4. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Dallol A; Morton D; Maher ER; Latif F Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722 [TBL] [Abstract][Full Text] [Related]
5. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729 [TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521 [TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Dickinson RE; Dallol A; Bieche I; Krex D; Morton D; Maher ER; Latif F Br J Cancer; 2004 Dec; 91(12):2071-8. PubMed ID: 15534609 [TBL] [Abstract][Full Text] [Related]
11. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
12. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas. Qu M; Jiao H; Zhao J; Ren ZP; Smits A; Kere J; Nistér M Neuropathol Appl Neurobiol; 2010 Apr; 36(3):198-210. PubMed ID: 20132488 [TBL] [Abstract][Full Text] [Related]
17. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Hesson L; Dallol A; Minna JD; Maher ER; Latif F Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574 [TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis. Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937 [TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]